Photocure (PHO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Photocure (PHO) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr26.43 Million ≈ $2.78 Million USD) by net assets (Nkr486.60 Million ≈ $51.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Photocure net asset quality index to measure how much of total assets are equity-financed.
Photocure - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Photocure's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Photocure cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Photocure Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Photocure ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Torrid Holdings Inc
NYSE:CURV
|
0.028x |
|
Rockfields Property Indonesia Pt
JK:ROCK
|
0.025x |
|
JF Technology BHD
KLSE:0146
|
0.023x |
|
Taliworks Corporation Bhd
KLSE:8524
|
0.013x |
|
Xiongan Kerong Environment Technology Co Ltd
SHE:300152
|
-0.004x |
|
Humacyte Inc
NASDAQ:HUMA
|
-8.403x |
|
Nnit AS
CO:NNIT
|
-0.076x |
|
Auk Corp
KO:017900
|
0.002x |
Annual Cash Flow Conversion Efficiency for Photocure (2002–2024)
The table below shows the annual cash flow conversion efficiency of Photocure from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see PHO stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr501.72 Million ≈ $52.79 Million |
Nkr76.75 Million ≈ $8.08 Million |
0.153x | +151.36% |
| 2023-12-31 | Nkr482.85 Million ≈ $50.81 Million |
Nkr29.39 Million ≈ $3.09 Million |
0.061x | +1495.53% |
| 2022-12-31 | Nkr462.73 Million ≈ $48.69 Million |
Nkr-2.02 Million ≈ $-212.35K |
-0.004x | -109.18% |
| 2021-12-31 | Nkr502.63 Million ≈ $52.89 Million |
Nkr23.89 Million ≈ $2.51 Million |
0.048x | +54.94% |
| 2020-12-31 | Nkr508.13 Million ≈ $53.47 Million |
Nkr15.59 Million ≈ $1.64 Million |
0.031x | -69.03% |
| 2019-12-31 | Nkr208.59 Million ≈ $21.95 Million |
Nkr20.66 Million ≈ $2.17 Million |
0.099x | +172.38% |
| 2018-12-31 | Nkr176.34 Million ≈ $18.56 Million |
Nkr-24.12 Million ≈ $-2.54 Million |
-0.137x | -26.45% |
| 2017-12-31 | Nkr218.08 Million ≈ $22.95 Million |
Nkr-23.59 Million ≈ $-2.48 Million |
-0.108x | -242.01% |
| 2016-12-31 | Nkr251.94 Million ≈ $26.51 Million |
Nkr19.19 Million ≈ $2.02 Million |
0.076x | +176.09% |
| 2015-12-31 | Nkr210.06 Million ≈ $22.10 Million |
Nkr-21.03 Million ≈ $-2.21 Million |
-0.100x | -294.80% |
| 2014-12-31 | Nkr240.06 Million ≈ $25.26 Million |
Nkr-6.09 Million ≈ $-640.63K |
-0.025x | +93.16% |
| 2013-12-31 | Nkr269.12 Million ≈ $28.32 Million |
Nkr-99.72 Million ≈ $-10.49 Million |
-0.371x | -156.53% |
| 2012-12-31 | Nkr380.27 Million ≈ $40.02 Million |
Nkr-54.93 Million ≈ $-5.78 Million |
-0.144x | -84.12% |
| 2011-12-31 | Nkr439.34 Million ≈ $46.23 Million |
Nkr-34.47 Million ≈ $-3.63 Million |
-0.078x | -330.80% |
| 2010-12-31 | Nkr458.85 Million ≈ $48.28 Million |
Nkr15.60 Million ≈ $1.64 Million |
0.034x | -95.55% |
| 2009-12-31 | Nkr415.78 Million ≈ $43.75 Million |
Nkr317.44 Million ≈ $33.40 Million |
0.763x | +355.48% |
| 2008-12-31 | Nkr199.69 Million ≈ $21.01 Million |
Nkr-59.68 Million ≈ $-6.28 Million |
-0.299x | +18.77% |
| 2007-12-31 | Nkr259.99 Million ≈ $27.36 Million |
Nkr-95.66 Million ≈ $-10.07 Million |
-0.368x | -281.35% |
| 2006-12-31 | Nkr326.94 Million ≈ $34.40 Million |
Nkr66.33 Million ≈ $6.98 Million |
0.203x | +113.94% |
| 2005-12-31 | Nkr48.47 Million ≈ $5.10 Million |
Nkr-70.54 Million ≈ $-7.42 Million |
-1.455x | -147.85% |
| 2004-12-31 | Nkr85.57 Million ≈ $9.00 Million |
Nkr-50.25 Million ≈ $-5.29 Million |
-0.587x | -9.86% |
| 2003-12-31 | Nkr131.90 Million ≈ $13.88 Million |
Nkr-70.51 Million ≈ $-7.42 Million |
-0.535x | -75.36% |
| 2002-12-31 | Nkr167.00 Million ≈ $17.57 Million |
Nkr-50.91 Million ≈ $-5.36 Million |
-0.305x | -- |
About Photocure
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more